A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 3,033,200 shares of RPRX stock, worth $78.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,033,200
Previous 2,096,300 44.69%
Holding current value
$78.4 Million
Previous $55.3 Million 55.23%
% of portfolio
0.21%
Previous 0.13%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$25.63 - $29.27 $24 Million - $27.4 Million
936,900 Added 44.69%
3,033,200 $85.8 Million
Q2 2024

Aug 14, 2024

BUY
$26.26 - $29.9 $15.1 Million - $17.2 Million
573,900 Added 37.7%
2,096,300 $55.3 Million
Q1 2024

May 15, 2024

SELL
$27.46 - $31.33 $13.1 Million - $15 Million
-478,700 Reduced 23.92%
1,522,400 $46.2 Million
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $47,178 - $52,596
1,800 Added 0.09%
2,001,100 $56.2 Million
Q3 2023

Nov 14, 2023

BUY
$26.26 - $31.38 $27.6 Million - $33 Million
1,051,700 Added 110.99%
1,999,300 $54.3 Million
Q2 2023

Aug 14, 2023

BUY
$29.6 - $36.56 $18.7 Million - $23.1 Million
631,000 Added 199.31%
947,600 $29.1 Million
Q1 2023

May 15, 2023

SELL
$32.77 - $39.4 $8.88 Million - $10.7 Million
-271,100 Reduced 46.13%
316,600 $11.4 Million
Q4 2022

Feb 14, 2023

SELL
$39.17 - $44.04 $4.74 Million - $5.33 Million
-121,100 Reduced 17.09%
587,700 $23.2 Million
Q3 2022

Nov 14, 2022

SELL
$39.88 - $44.65 $1.72 Million - $1.93 Million
-43,200 Reduced 5.74%
708,800 $28.5 Million
Q2 2022

Aug 15, 2022

BUY
$37.53 - $44.22 $12.9 Million - $15.2 Million
344,600 Added 84.59%
752,000 $31.6 Million
Q1 2022

May 16, 2022

BUY
$37.46 - $42.44 $5 Million - $5.66 Million
133,400 Added 48.69%
407,400 $15.9 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $6.22 Million - $7.51 Million
176,800 Added 181.89%
274,000 $10.9 Million
Q3 2021

Nov 15, 2021

BUY
$36.14 - $42.24 $3.51 Million - $4.11 Million
97,200 New
97,200 $3.51 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.3B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.